InvenireX
PrivateLast Round
Seed
Nov 18, 2025
Total Funding Raised
$3.14M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
InvenireX operates in Healthcare & Life Sciences and is based in Newcastle upon Tyne. Its latest recorded funding round was a Seed round in November 2025.
InvenireX is a biotechnology company that develops an ultra-sensitive, real-time nucleic acid detection platform powered by DNA nanotechnology and artificial intelligence for use in molecular diagnostics and life sciences research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Devices, Medical AI
Business Model
B2B
Customer Profile
Hardware + Subscription, Government Contracts, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InvenireX Comparables
Compare InvenireX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nanovery | 81% | |
| Nanopath | 81% | |
| Aligned Bio | 78% |
For institutional investors. Book with your work email.
InvenireX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 18, 2025 | ||||
| Seed | Mar 18, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
InvenireX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Seed |
| XTX Ventures | Seed |
| DSW Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 18, 2025
$2.6M raised led by DSW Ventures.
- Nov 12, 2025
Grew 100% QoQ from 5 to 10 employees.
For institutional investors. Book with your work email.
InvenireX Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about InvenireX's valuation, stock price, and market status.
Is InvenireX a public or private company?
InvenireX is a private company.
What is the current stock price of InvenireX?
InvenireX is a private company, so its shares have no public market price. Caplight tracks InvenireX's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is InvenireX worth (valuation)?
Valuation information for InvenireX is not publicly available.
Can I buy InvenireX stock?
InvenireX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was InvenireX's last funding round?
InvenireX's most recent funding round was Seed on November 18, 2025.
Who are the main investors in InvenireX?
Key investors in InvenireX include DSW Ventures.
Will InvenireX IPO soon?
No public IPO plans have been announced for InvenireX.
How can I track InvenireX secondary market activity?
Caplight tracks bids, offers, and trades in InvenireX's shares on secondary markets.